SAN DIEGO--(BUSINESS WIRE)--April 3, 2006--AVANIR Pharmaceuticals (AMEX:AVN.R - News) announced today that the NASDAQ® has approved the Company's application for listing on the NASDAQ National Market System. Consistent with NASDAQ guidance, trading is expected to begin on Tuesday, April 11, under the new ticker symbol "AVNR." Until that time, AVANIR's stock will continue to trade on the American Stock Exchange under the symbol "AVN.R."
